Abstract 2928: Evaluating Cks1-Skp2 interface as an effective therapeutic target forRB1-deficient metastatic castration-resistant prostate cancer (mCRPC)

2021 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []